In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain. (Q44645217)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15327647 AND SRC:MED&resulttype=core&format=json

1 January 2020

title

In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15327647 AND SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15327647 AND SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Alvarez M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15327647 AND SRC:MED&resulttype=core&format=json

1 January 2020

Limeres J

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15327647 AND SRC:MED&resulttype=core&format=json

1 January 2020

Otero JL

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15327647 AND SRC:MED&resulttype=core&format=json

1 January 2020

Saavedra E

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15327647 AND SRC:MED&resulttype=core&format=json

1 January 2020

López-Meléndez C

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15327647 AND SRC:MED&resulttype=core&format=json

1 January 2020

Diz P

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15327647 AND SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 October 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15327647 AND SRC:MED&resulttype=core&format=json

Oral Microbiology and Immunology

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15327647 AND SRC:MED&resulttype=core&format=json

1 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15327647 AND SRC:MED&resulttype=core&format=json

1 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15327647 AND SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

331-335

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15327647 AND SRC:MED&resulttype=core&format=json

In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1399-302X.2004.00167.X

High prevalence of erythromycin-resistant and clindamycin-susceptible (M phenotype) viridans group streptococci from pharyngeal samples: a reservoir of mef genes in commensal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-302X.2004.00167.X

A survey of antibiotic use in dentistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-302X.2004.00167.X

What happened to the streptococci: overview of taxonomic and nomenclature changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-302X.2004.00167.X

The oral cavity as a reservoir of bacterial pathogens for focal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-302X.2004.00167.X

The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-302X.2004.00167.X

Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-302X.2004.00167.X

Multidrug Resistance — A Sign of the Times

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-302X.2004.00167.X

Systemic diseases caused by oral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-302X.2004.00167.X

High proportion of pharyngeal carriers of commensal streptococci resistant to erythromycin in Spanish adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-302X.2004.00167.X

Distribution of mef(A) and erm(B) genes in macrolide-resistant blood isolates of viridans group streptococci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-302X.2004.00167.X

Miscellaneous catalase-negative, gram-positive cocci: emerging opportunists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-302X.2004.00167.X

A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-302X.2004.00167.X

In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-302X.2004.00167.X

Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-302X.2004.00167.X

In vitro activity of novel fluoroquinolones against Streptococcus pneumoniae isolated from children with acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1399-302X.2004.00167.X